Latest Breaking News On - Immunisation centre at sefako makgatho university - Page 1 : vimarsana.com

Phase two of South Africa’s Covid-19 vaccine rollout aiming to vaccinate citizens over the age of 60 years is underway and members of the public are being asked to report any mild, moderate or severe adverse events experienced after receiving their jabs. Reporting adverse events is a critical part of monitoring vaccine safety once a vaccine has been rolled out to the broader population. The timeous reporting specifically of serious adverse events means a specialist review or causality committee can either rule out or confirm whether there is a link to the vaccine. Spotlight has been alerted to calls by an “independent” online organisation for members of the public to report adverse events they may experience on the organisation’s site.

South africaSouth africanHannelie meyerFlorah matlalaAfrica covidSchool of pharmacyHs programmeAfrican health products regulatory authorityNational institute of communicable diseaseImmunisation centre at sefako makgatho universityGoogle play store or apple appNational department of healthDepartment of healthAfrican union smart safety solutionsNational immunisation safety expert committeeNational department